5 Common Challenges for Genetics-Based
Clinical Trials — and How to Overcome Them

Conducting a clinical trial of any kind is complex. Including genetic screening can introduce nuances and complications that increase the complexity even more. Understanding the unique obstacles genetic information presents and how to strategically navigate them is paramount to trial progress and success.

By leveraging its deep and broad genetics expertise, InformedDNA understands how to navigate these challenges and collaborates with clinical trial sponsors to overcome them.

InformedDNA is the largest full-service genetic advisory company, with a suite of offerings for clinical trial sponsors and CROs designed to support clinical trials, natural history studies, and research programs. Our services are optimized to reduce time to enrollment, increase screening efficiencies, improve patient retention, mitigate sponsor risk, and reduce clinical trial costs.

This article, published in Clinical Leader, provides an industry overview of the top challenges genetic screening poses for trials. And, it includes proactive strategies to address the challenges, ensuring you gain impactful insights and data needed for trial success.

 

Click here to download the article now

 

 

 

To learn more about how to address common challenges in clinical trials for rare disease therapies, just submit the short form below.